Alcohol and red wine: Impact on cardiovascular risk

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 11-16

  Böhm, Michael ^a   Rosenkranz, Stephan ^b   Laufs, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Alcohol; Cardiovascular risk; Coronary heart disease; French Paradox; Myocardial infarction; Platelet derived growth factor receptor

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; C REACTIVE PROTEIN; CATECHIN; FIBRINOGEN; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; PHENOL DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; POLYPHENOL; PRAVASTATIN; QUERCETIN; RESVERATROL; TANNIN; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY RISK; CORRELATION FUNCTION; DRUG MECHANISM; DRUG POTENCY; EDITORIAL; FAT INTAKE; HEART INFARCTION; HEART PROTECTION; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LIVER CANCER; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; NUTRITIONAL VALUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RED WINE; RISK FACTOR; RISK MANAGEMENT; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; BLOOD VESSELS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ETHANOL; FEMALE; HUMANS; LIPIDS; MALE; MUSCLE, SMOOTH, VASCULAR; RISK FACTORS; WINE;

EID: 17944403223     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg340     Document Type: Editorial

References (45)

1. Dyer AR, Stamler J, Paul O et al. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company Study. Prev Med 1980; 9: 78-90
2. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986; 124: 481-489
3. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992; 117: 646-654
4. Klatsky AL, Friedman GD, Siegelaub AB. Alcohol use and cardiovascular disease: the Kaiser-Permanente experience. Circulation 1981; 64: 32-41
5. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994; 5: 73-82
6. Rimm EB, Giovannucci EL, Willet WC et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468
7. Rimm EB, Stampfer MJ. Wine, beer, and spirits. Are they really horses of a different color? Circulation 2002; 105: 2806-2807
8. de Lorgeril M, Salen P, Marin JL, Boucher F, Paillard F, de Leiris J. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 2002; 106: 1465-1469
9. Renaud SG, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992; 55: 1012-1017
10. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French Paradox for coronary heart disease. Lancet 1992; 339: 1523-1526
11. Criqui MH, Ringel BL. Does diet or alcohol explain the French Paradox? Lancet 1994; 344: 1719-1723
12. Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000; 19: 411-419
13. Gronbaek M, Dies A, Sorensen TIA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits, Br Med J 1995; 10: 1165-1169
14. Goldberg U, Mosca L, Piano MR, Fisher EA. Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001; 103: 472-475
15. Truelsen T, Gronbaek M, Schnohr P, Boysen G. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen City Heart Study. Stroke 1998; 29: 2467-2472
16. Mukamal K, Conigrave K, Mittleman M et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109-118
17. McElduff P, Dobson AJ. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. Br Med J 1997; 314: 1159-1164
18. Hines LM, Stampfer MJ, Ma J et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001; 344: 549-555
19. Camacho TC, Kaplan GA, Cohen RD. Alcohol consumption and mortality in Alameda County. J Chronic Dis 1987; 40: 229-236
20. National Center for Health Statistics. Vital Statistics of the United States: Mortality Series. Government Printing Office, Washington, DC: 1968-1988
21. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322: 95-99
22. Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol cirrhosis in women. Br Med J 1987; 295: 8082
23. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA 2001; 285: 1965-1970
24. de Oliveira E, Silva ER, Foster D et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000; 102: 2347-2352
25. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-1834
26. Nishikawa M, Ishikawa T, Ito T et al. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis 1994; 111: 99-109
27. Pace-Asiak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis. Implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-219
28. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130: 53-56
29. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; 1: 153-156
30. Rogers S, Yarnell JWG, Fehily AM. Nutritional determinants of haemostatic factors in the Caerphilly study. Eur J Clin Nutr 1988; 42: 197-205
31. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994; 344: 193-194
32. Luis AJ. Atherosclerosis. Nature 2000; 407: 233-241
33. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457
34. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
35. Albert M, Glynn R, Ridker P. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107: 1-5
36. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001; 12: 383-389
37. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
38. Flesch M, Schwarz A, Böhm M. Different effects of red and white wine on endothelial-dependent vasorelaxation of coronary arteries. Am J Physiol 1998; 275: H1183-H1190
39. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary flow-velocity reserve. Lancet 1999; 354: 1002
40. Teragawa H, Fukuda Y, Matsuda K et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 2002; 165: 145-152
41. Wallerath T, Deckert G, Ternes T et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002; 106: 1652-1658
42. Flesch M, Erdmann E, Böhm M. Alkohol und Myokardinfarkt. Epidemiologische und experimentelle Untersuchungen zum Einfluss von Alkohol auf Gefässrelaxation und Koronarsklerose. Dtsch Med Wschr 1998; 123: 1490-1496
43. Sano H. Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 2001; 103: 2955-2960
44. Hart CE. PDGF β receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 1999; 99: 564-569
45. Rosenkranz S, Knirel D, Dietrich H, Flesch M, Erdmann E, Böhm M. Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the 'French Paradox'. FASEB J 2002; 16: 1958-1960